Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug

Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug

  • March 3, 2026

Disc Medicine is laying off a fifth of its workforce as the biotech reels from the FDA’s rejection of its rare blood disease candidate.

Leave A Comment

Fields (*) Mark are Required